AstraZeneca: We may be able to vaccinate at the end of December

Russia closes a black web page: after 9 years the ‘Volga strangler’ fell

The 38-year-old is accused of murdering at the very least 26 older ladies since 2011.A web page in Russia's black historical past was closed...

Vestager: “Europe misplaced the primary wave of digitization, however we’ve got realized from errors”

Vice President Calviño mentioned within the 'Europa Futura' cycle, organized by EL PAÍS, that she believes that Spain will develop within the fourth quarterGoogle,...

Israel, one step away from new elections in lower than two years

Parliament accredited a movement for its dissolution as a result of lack of consensus within the coalition Govt to approve the price range. ...

France offers away 10 days of paid trip to staff in sectors affected by the pandemic

The French Authorities introduced this Wednesday that it's going to subsidize ten days paid trip to all employees within the sectors most affected by...

Germany extends its restrictions resulting from covid-19 till January 10

The present ones restrictions of public life in Germany They are going to be anticipated to stay till January 10, the German Chancellor...

People may be vaccinated with the vaccine from pharmaceutical AstraZeneca by the end of this year. That says CEO Pascal Soriot of the company in the Swedish newspaper on Saturday Today’s News.

Exactly when the vaccine can be used depends on regulatory approval. “If they act quickly when our vaccine is ready, we can start vaccinating people in January, maybe even by the end of December,” Soriot said.

The British-Swedish pharmaceutical company is collaborating with the University of Oxford on a corona vaccine. The potential vaccine is currently in its third stage of development. This means that the drug is tested on tens of thousands of people.

Research into the vaccine was halted for a week in September after one of the British subjects developed potentially serious side effects. After the UK government’s oversight committee concluded that it was safe to proceed, the investigation could be resumed.

The potential vaccine from AstraZeneca is seen by the WHO health organization as the most promising. The European Commission has already signed a deal with AstraZeneca and hopes to receive 300 million doses if the vaccine is approved.



Related Articles